[page 48]

Product Name

Molecular Formula

Sequence

ATALGLSSRGLLPIGFMFKDTIRCRKY

C₁₄₂H₂₂₈N₄₂O₃₅S

H-ATAWDFGPHGLLPIRPIRIRPLCGKDKS-OH

VEVQVRDKGKGIYGLSPLRQPTP

VEVQVREVGIQGLSPLRQPAP

VEVQVRDKGKGIYGLSPLRQPAP

VEVQVRAVGIQGLSPLRQPAP

GLFTLIKGAAKLIGKTVPKKQARLGMNLWLVKLPTNVKT

Odorranain-J-OA2

GLFTLIKGAYKNDAPTVACN

Odorranain-J-OA1

GLFTLIKGAYKLDAPTVACN

Odorranain-I1 antimicrobial peptide

GFFTLIKAANKLINKTVNKEAGKGGLEIMA

GLLRASSVWGRKYYVDLAGCAKA

GIFGKILGVGKKVLCGLSGMW

GLGGAKKNFIIAANKTAPQSVKKTFSCKLYNG

C₁₃₉H₂₄₃N₃₉O₄₅S₂

H-GVPGTVKDLLIGAGKSAAQSVLKALSCKLSNDC-OH

ATAWDFGPHGLLPIRPIRIRPLCGKDKS

C₄₉H₆₄N₁₀O₁₁S₂

H-fCFwKTCT-OH, disulfide bond: Cys2-Cys7

Octalysine (K8)

C₄₈H₉₈N₁₆O₉

H-KKKKKKKK-OH

Octadecaneuropeptide ODN

C₈₁H₁₃₈N₂₄O₂₉

QATVGDVNTDRPGLLDLK

GVLDILTGAGKDLLAHALSKLSEKV

GVLDILKGAGKDLLAHALSKISEKV

GVVDILKGAGKDLLAHALSKLSEKV

GVLDILKGAAKDLAGHVATKVINKI

C₁₁₂H₂₀₁N₃₁O₃₃S

GLLDTLKGAAKNVVGSLASKVMEKL

C₁₁₃H₁₉₉N₃₃O₃₁S

GVVDILKGAAKDIAGHLASKVMNKL

C₉₈H₁₆₉N₂₉O₂₈

GVLDILKNAAKNILAHAAEQI

C₁₀₈H₁₈₀N₃₀O₃₀

GVLDIFKDAAKQILAHAAEKQI

C₁₁₆H₂₀₄N₃₂O₃₂

GVVDILKGAGKDLLAHLVGKISEKV

C₁₀₇H₁₇₆N₂₆O₂₈

H-GLLDFVTGVGKDIFAQLIKQI-NH2

Obestatin(11-23)

C₆₁H₉₈N₂₂O₁₈

LSGAQYQQHGRAL

Obestatin (human)

C₁₁₆H₁₇₆N₃₂O₃₃

FNAPFDVGIKLSGVQYQQHSQAL-NH2

C₁₁₄H₁₇₄N₃₄O₃₁

FNAPFDVGIKLSGAQYQQHGRAL

C₃₇H₆₂N₁₄O₁₂S₂

H-CSSPIGRHC-OH

NY-ESO-1 (87-111)

C₁₃₁H₂₀₆N₃₂O₃₆S₂

H-LLEFYLAMPFATPMEAELARRSLAQ-OH

NY-ESO-1 (157-165)/ESO 9C

C₄₉H₇₉N₁₁O₁₃S₂

H-SLLMWITQC-OH

NY-ESO-1 - HLA-A*0201

C₄₉H₇₉N₁₁O₁₃S₂

H-SLLMWITQC-OH

NVG-291, TAT-ISP (Human), >98% purity

C₁₇₆H₃₀₄N₆₆O₅₅S₂

GRKKRRQRRRCDMAEHTERLKANDSLKLSQEYESI-NH2

NVG-291-R, TAT-ISP (Rodent)

C₁₇₇H₃₀₆N₆₆O₅₄S₃

H-GRKKRRQRRRCDMAEHMERLKANDSLKLSQEYESI-NH2

C₇₀H₁₂₆N₃₀O₂₀

H-SGRGKGGKGLGKGGAKRH-OH

Nuclear Factor NF-KB Inhibitor SN50

C₁₂₉H₂₃₀N₃₆O₂₉S

AAVALLPAVLLALLAPVQRKRQKLMP

C₆₉H₁₂₄N₂₂O₁₉

Acetylation-ATLDALLAALRRIQ-NH2